Millions of people who could benefit from statins have stopped taking them or never started, largely because they fear muscle ...
Intolerance to statin therapy appears to be much lower than previous data suggest, with researchers reporting that less than one in 10 patients are unable to tolerate the guideline-recommended, LDL ...
As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side effects. Now, a new ...
Millions of people who take statins, or who have stopped taking them because of reported side effects, now face a sharp ...
On the first day here in New Orleans at the 2023 American College of Cardiology (ACC) meeting, we learned the details of the placebo-controlled CLEAR Outcomes trial of bempedoic acid in ...
A substantial percentage of patients report intolerance or side effects of statin treatment leading to treatment changes or discontinuation. The purpose of this study was to examine statin therapy ...
NEW ORLEANS -- Bempedoic acid (Nexletol) provided compelling clinical benefit in terms of primary and secondary cardiovascular prevention for statin-intolerant patients who need cholesterol lowering, ...
Statin intolerance is far less common than previously reported, according to a new meta-analysis, with data on more than 4 million adults from around the world, looking at reported statin adverse ...
Bempedoic acid is associated with a reduction in major adverse cardiovascular events among statin-intolerant primary prevention patients, according to a study published online June 24 in the Journal ...
As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side-effects. Now, a new ...
Those who took bempedoic acid once a day had on average a 30.2 mg/dL or 21.3% reduction in low-density lipoprotein (LDL) cholesterol levels over about a three-year period. Elevated LDL levels can lead ...
As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side-effects. Now, a new ...